Giorgia Giordani

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The efficient treatment of hematological malignancies as Acute Myeloid Leukemia, myelofibrosis and Chronic Myeloid Leukemia, requires the elimination of cancer-initiating cells and the prevention of disease relapse through targeting pathways that stimulate generation and maintenance of these cells. In mammals, inhibition of Smoothened, the key mediator of(More)
  • 1